Spironolactone Tablet, Film Coated
Product Images NDC 71335-0401

4 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 71335-0401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (Lbl713350401)

Label (Lbl713350401)
Label for Spironolactone 50 mg tablet, packaged by Bryant Ranch Prepack in Burbank, CA. The label indicates the product is to be compared to Aldactone 50 mg tablet by Intas Pharmaceuticals Limited. It includes handling instructions to keep drugs out of children's reach and store at 20°-25°C (68°-77°F). The package size is 30 tablets and displays the NDC 71335-0401-1 along with a barcode.*
FDA Label Image

Figure 1 (Spironolactone Figure 1)

Figure 1 (Spironolactone Figure 1)
A Kaplan-Meier survival probability plot comparing Spironalactone (likely a misspelling of Spironolactone) to placebo over 48 months. The Y-axis shows probability decreasing from 1.0 to 0.0, and the X-axis shows time in months. The plot shows higher survival probability for Spironolactone compared to placebo, with a statistically significant log-rank p-value below 0.001.*
FDA Label Image

Figure 2 (Spironolactone Figure 2)

Figure 2 (Spironolactone Figure 2)
A forest plot chart illustrating the hazard ratios (HR) with 95% confidence intervals (CI) for various subgroups comparing Spironolactone versus placebo. The subgroups include age, sex, race, LVEF percentages, heart failure type, NYHA class, diabetes status, serum creatinine levels, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. Each comparison shows the HR point estimate with confidence intervals and the number and percentage of participants in each subgroup.*
FDA Label Image

Chemical Structure (Spironolactone Structure Image)

Chemical Structure (Spironolactone Structure Image)
Chemical structure diagram of Spironolactone, showing its steroid core with attached functional groups including keto and thioacetyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.